Compass Therapeutics, Inc. (CMPX)

Compass Therapeutics Statistics

Total Valuation

CMPX has a market cap or net worth of $396.19 million. The enterprise value is $243.71 million.

Market Cap	396.19M
Enterprise Value	243.71M

Important Dates

The last earnings date was Tuesday, May 5, 2026, before market open.

Earnings Date	May 5, 2026
Ex-Dividend Date	n/a

Share Statistics

CMPX has 180.09 million shares outstanding. The number of shares has increased by 23.18% in one year.

Current Share Class	180.09M
Shares Outstanding	180.09M
Shares Change (YoY)	+23.18%
Shares Change (QoQ)	+0.84%
Owned by Insiders (%)	5.85%
Owned by Institutions (%)	73.67%
Float	122.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.30
P/TBV Ratio	2.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 19.04, with a Debt / Equity ratio of 0.05.

Current Ratio	19.04
Quick Ratio	18.94
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -45.95% and return on invested capital (ROIC) is -30.03%.

Return on Equity (ROE)	-45.95%
Return on Assets (ROA)	-27.91%
Return on Invested Capital (ROIC)	-30.03%
Return on Capital Employed (ROCE)	-38.57%
Weighted Average Cost of Capital (WACC)	7.73%
Revenue Per Employee	n/a
Profits Per Employee	-$1.75M
Employee Count	39
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.91% in the last 52 weeks. The beta is 0.67, so CMPX's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	+6.91%
50-Day Moving Average	3.68
200-Day Moving Average	4.50
Relative Strength Index (RSI)	40.73
Average Volume (20 Days)	6,083,195

Short Selling Information

The latest short interest is 31.02 million, so 17.23% of the outstanding shares have been sold short.

Short Interest	31.02M
Short Previous Month	30.42M
Short % of Shares Out	17.23%
Short % of Float	25.28%
Short Ratio (days to cover)	2.06

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-75.17M
Pretax Income	-68.17M
Net Income	-68.17M
EBITDA	-75.02M
EBIT	-75.17M
Earnings Per Share (EPS)	-$0.40

Balance Sheet

The company has $194.69 million in cash and $9.79 million in debt, with a net cash position of $184.90 million or $1.03 per share.

Cash & Cash Equivalents	194.69M
Total Debt	9.79M
Net Cash	184.90M
Net Cash Per Share	$1.03
Equity (Book Value)	186.47M
Book Value Per Share	1.04
Working Capital	185.41M

Cash Flow

In the last 12 months, operating cash flow was -$53.20 million and capital expenditures -$89,000, giving a free cash flow of -$53.29 million.

Operating Cash Flow	-53.20M
Capital Expenditures	-89,000
Depreciation & Amortization	151,000
Net Borrowing	n/a
Free Cash Flow	-53.29M
FCF Per Share	-$0.30

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CMPX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.18%
Shareholder Yield	-23.18%
Earnings Yield	-15.91%
FCF Yield	-12.43%

Analyst Forecast

The average price target for CMPX is $8.82, which is 300.91% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.82
Price Target Difference	300.91%
Analyst Consensus	Strong Buy
Analyst Count	14
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2